Dean J. Kereiakes
Expertise in
35
conditions

Dr. Dean J. Kereiakes

Interventional Cardiology | Cardiology
The Christ Hospital Cardiovascular Associates LLC
2123 Auburn Ave, 
Cincinnati, OH 
Accepting New Patients
Expertise in
35
conditions
The Christ Hospital Cardiovascular Associates LLC
2123 Auburn Ave, 
Cincinnati, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dean Kereiakes is an Interventional Cardiologist and a Cardiologist in Cincinnati, Ohio. Dr. Kereiakes is highly rated in 35 conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Aortic Valve Stenosis, Aortic Regurgitation, Lithotripsy, and Percutaneous Coronary Intervention (PCI). Dr. Kereiakes is currently accepting new patients.

His clinical research consists of co-authoring 271 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Interventional Cardiology
Cardiology
Licenses
Internal Medicine in OH
Hospital Affiliations
Mercy Health-Anderson Hospital
Christ Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medical Health
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 2 Less Insurance Carriers -

Locations

THE CHRIST HOSPITAL CARDIOVASCULAR ASSOCIATES LLC
2123 Auburn Ave, Cincinnati, OH 45219

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
Enrollment Status: Active_not_recruiting
Publish Date: June 05, 2025
Intervention Type: Drug
Study Drug: TQJ230
Study Phase: Phase 3
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
Enrollment Status: Active_not_recruiting
Publish Date: April 27, 2025
Intervention Type: Device
Study Phase: Not Applicable
Personalized Therapy Study - Heart Failure Risk Status (TriageHF) Post Approval Study
Personalized Therapy Study - Heart Failure Risk Status (TriageHF) Post Approval Study
Enrollment Status: Active_not_recruiting
Publish Date: April 01, 2025
Intervention Type: Other
An Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF) - The CorCinch-HFrEF Study
An Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF) - The CorCinch-HFrEF Study
Enrollment Status: Active_not_recruiting
Publish Date: January 30, 2025
Intervention Type: Device
Study Phase: Not Applicable
Early Feasibility Study of the AccuCinch® Ventricular Restoration System
Early Feasibility Study of the AccuCinch® Ventricular Restoration System
Enrollment Status: Completed
Publish Date: January 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Phase 1 Dose-Escalation Study in Healthy Volunteers and Subjects on Aspirin With Stable Coronary Artery Disease to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RUC-4
A Randomized Phase 1 Dose-Escalation Study in Healthy Volunteers and Subjects on Aspirin With Stable Coronary Artery Disease to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RUC-4
Enrollment Status: Completed
Publish Date: August 27, 2024
Intervention Type: Drug
Study Phase: Phase 1
An Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation - The CorCinch-PMVI Study
An Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation - The CorCinch-PMVI Study
Enrollment Status: Completed
Publish Date: August 16, 2024
Intervention Type: Device
Study Phase: Not Applicable
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients With Symptomatic, Severe Aortic Regurgitation (AR)
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients With Symptomatic, Severe Aortic Regurgitation (AR)
Enrollment Status: Active_not_recruiting
Publish Date: September 13, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Prospective, Randomized, Adaptive, Double-Blind, Sham-Controlled, Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension
A Prospective, Randomized, Adaptive, Double-Blind, Sham-Controlled, Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension
Enrollment Status: Terminated
Publish Date: May 13, 2019
Intervention Type: Other, Device
Study Phase: Not Applicable
Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
Enrollment Status: Terminated
Publish Date: June 23, 2017
Intervention Type: Device
Study Phase: Phase 3
View 11 Less Clinical Trials

271 Total Publications

Beyond the guidelines: expert perspectives on the management of AMI-related cardiogenic shock from the cardiovascular research technologies (CRT) 2025 meeting.
Beyond the guidelines: expert perspectives on the management of AMI-related cardiogenic shock from the cardiovascular research technologies (CRT) 2025 meeting.
Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: May 05, 2025
Similar Doctors
Timothy D. Henry
Expertise in
24
conditions
Dr. Timothy D. Henry
Interventional Cardiology | Cardiology
Expertise in
24
conditions
Dr. Timothy D. Henry
Interventional Cardiology | Cardiology

The Christ Hospital Cardiovascular Associates LLC

2123 Auburn Ave, 
Cincinnati, OH 
 (0.1 mi)
513-721-8881
Experience:
43+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Timothy Henry is an Interventional Cardiologist and a Cardiologist in Cincinnati, Ohio. Dr. Henry has been practicing medicine for over 43 years is highly rated in 24 conditions, according to our data. His top areas of expertise are Heart Attack, Angina, Cardiogenic Shock, Percutaneous Coronary Intervention (PCI), and Bone Marrow Aspiration. Dr. Henry is currently accepting new patients.

Expertise in
31
conditions
Dr. Jerome B. Schutzman
Interventional Cardiology | Cardiology
Expertise in
31
conditions
Dr. Jerome B. Schutzman
Interventional Cardiology | Cardiology

Summit Medical Group Inc

900 Medical Village Dr, 
Edgewood, KY 
 (8.3 mi)
859-331-0774
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jerome Schutzman is an Interventional Cardiologist and a Cardiologist in Edgewood, Kentucky. Dr. Schutzman is highly rated in 31 conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Angina, Atherosclerosis, and High Cholesterol. Dr. Schutzman is currently accepting new patients.

Expertise in
19
conditions
Dr. Mark K. Jordan
Interventional Cardiology | Cardiology | Vascular Surgery
Expertise in
19
conditions
Dr. Mark K. Jordan
Interventional Cardiology | Cardiology | Vascular Surgery

Summit Medical Group Inc

711 Medical Village Dr, 
Edgewood, KY 
 (8.2 mi)
859-331-3353
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mark Jordan is an Interventional Cardiologist and a Cardiologist in Edgewood, Kentucky. Dr. Jordan is highly rated in 19 conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Angina, Atherosclerosis, Peripheral Artery Disease, and Pacemaker Implantation. Dr. Jordan is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kereiakes's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 22 Advanced Conditions
View All 41 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile